Need help understanding this study?
Leave your email and we’ll get in touch to discuss your questions and possible next steps.
Not recruitingISRCTN28588282
Efficacy and safety of agomelatine given orally compared to placebo, in addition to a mood stabiliser in bipolar I patients with a current major depressive episode. An eight week randomised, double-blind, controlled, parallel group study followed by a double-blind extension treatment period up to one year
Research studyAges 18+FranceDepression
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- France
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Institut de Recherches Internationales Servier (France)
- Sponsor type
- Research institute
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN28588282
- Official title
Show the full official title
Efficacy and safety of agomelatine given orally compared to placebo, in addition to a mood stabiliser in bipolar I patients with a current major depressive episode. An eight week randomised, double-blind, controlled, parallel group study followed by a double-blind extension treatment period up to one year
Recruitment & locations
Not recruitingFrance
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Institut de Recherches Internationales Servier (France), a research institute.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingISRCTN83632872
Child resilience in Afghanistan study
France, Afghanistan
Not recruitingISRCTN73157235
Effects of a prenatal program group led to parental couples to prevent postpartum depression in women of middle and lower classes living in northern Catalonia and Southern France [Effetsdunprogrammeprénatal de groupeadresséauxcouplesparentauxpourprévenir la dépressionpostnatale des femmes de clases moyenne et défavoriséehabitant en Catalogne Nord et en France Sud]
France, Spain
Not recruitingISRCTN44737909
Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in people with major depressive disorder: a six-week parallel group study versus comparator, followed by a optional treatment extension period up to six months
Australia, France, United Kingdom, + 6 others